Morocco's national oncology institute, the reference cancer centre of the Rabat university hospital and the anchor of the Lalla Salma Foundation's national cancer plan.
The Institut National d'Oncologie Sidi Mohamed Ben Abdellah in Rabat opened in 1985 as Morocco's national cancer institute within the Ibn Sina University Hospital Centre (CHU Ibn Sina) and the Université Mohammed V medical school, providing surgical, medical and radiation oncology, brachytherapy, nuclear medicine and paediatric oncology as the national referral centre. With the Fondation Lalla Salma (Prévention et traitement des cancers), founded in 2005 by Princess Lalla Salma, INO has led Morocco's national cancer prevention and control plan, which built regional oncology centres, introduced free breast and cervical screening, expanded radiotherapy and palliative care and improved access to cancer medicines across the country. INO researchers publish on breast and cervical cancer in North African women, nasopharyngeal carcinoma, which is common in the Maghreb, and cancer registration for Rabat.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-15.
Matched to Institut National d'Oncologie, including child institutions. 64 works · 104 citations · 69% open access · 5% clinical trials · 5% reviews.
Shares WHO Essential Medicines List for cancer, Global oncology and access in low- and middle-income countries, Brachytherapy, HPV & HBV vaccination.
Shares Global oncology and access in low- and middle-income countries, Brachytherapy, Cervical cancer, Head and neck squamous cell carcinoma.
Shares WHO Essential Medicines List for cancer, Global oncology and access in low- and middle-income countries, Brachytherapy, HPV & HBV vaccination.
Shares Global oncology and access in low- and middle-income countries, Brachytherapy, HPV & HBV vaccination, Cervical cancer.
Shares Global oncology and access in low- and middle-income countries, Brachytherapy, Cervical cancer, Head and neck squamous cell carcinoma.
Shares Global oncology and access in low- and middle-income countries, HPV & HBV vaccination, Cervical cancer, Head and neck squamous cell carcinoma.
Shares Global oncology and access in low- and middle-income countries, Brachytherapy, HPV & HBV vaccination, Cervical cancer.
Shares Global oncology and access in low- and middle-income countries, Brachytherapy, HPV & HBV vaccination, Cervical cancer.